Waves come ashore, Saturday, Sept. 15, 2023, in Hampton Beach, N.H. (AP Photo/Michael Dwyer)
With warmer oceans serving as fuel, Atlantic hurricanes are now more than twice as likely as before to rapidly intensify from wimpy minor hurricanes to powerful and catastrophic, a study said Thursday.
Last month Hurricane Lee went from barely a hurricane at 80 mph (129 kph) to the most powerful Category 5 hurricane with 155 mph (249 kph) winds in 24 hours. In 2017, before it devastated Puerto Rico, Hurricane Maria went from a Category 1 storm with 90 mph (145 kph) to a top-of-the-chart whopper with 160 mph (257 kph) winds in just 15 hours.
The study looked at 830 Atlantic tropical cyclones since 1971. It found that in the last 20 years, 8.1% of the time storms powered from a Category 1 minor storm to a major hurricane in just 24 hours. That happened only 3.2% of the time from 1971 to 1990, according to a study in the journal Scientific Reports. Category 1 hurricanes top out at 95 mph (153 kph) and a hurricane has to have at least 111 mph (178 kph) winds to become major.
Those are the most extreme cases, but the fact that the rate of such turbocharging has more than doubled is disturbing, said study author Andra Garner, a climate scientist at Rowan University in New Jersey.
When storms rapidly intensify, especially as they near land, it makes it difficult for people in the storm’s path to decide on what they should do — evacuate or hunker down. It also makes it harder for meteorologists to predict how bad it will be and for emergency managers to prepare, Garner and other scientists said.
“We know that our strongest, most damaging storms very often do intensify very quickly at some point in their lifetimes,” Garner said, highlighting 2017's Maria, which some researchers said killed nearly 3,000 people directly and indirectly. “We’re talking about something that’s hard to predict that certainly can lead to a more destructive storm.”
And this “has become more common in the last 50 years,” Garner said. “This has all happened over a time period when we’ve seen ocean waters get warmer.”
“We’ve had 90% of the excess warming that humans have caused to the planet going into our oceans,” Garner said.
Garner found the rapid intensification of hurricanes was primarily along the East Coast’s Atlantic seaboard, more so than the Gulf of Mexico.
It’s not just the cases of extreme rapid intensification. Garner looked at all storms over different time periods and found that in general they’re intensifying faster than they used to.
There have been more Atlantic storms in the last few decades than in the 1970s and 1980s – scientists have several theories for why, from changes in air pollution to natural cycles – but Garner said by looking at percentages she took out the storm frequency factor.
Previous studies had found an increase in rapid intensification. Garner’s study was statistically meticulous in confirming what scientists had figured, said Karthik Balaguru, a Pacific Northwest National Lab climate scientist who last year had a paper demonstrating how storms near the Atlantic coast are intensifying faster before landfall than they did in the 1970s and 1980s.
The National Hurricane Center considers a storm to rapidly intensify if it increases wind speed by 35 mph (46 kph) in 24 hours.
In 2020, a record year for hurricanes and the last year of Garner’s study, six storms rapidly intensified that much. Hannah, Laura, Sally, Teddy, Gamma and Delta. Since then, there have been several rapid intensifying and deadly storms, including 2021’s Ida, 2022’s Ian and 2023’s Idalia.
“If we don't work to lower our (carbon) emissions, then that's a trend that we likely could expect to see continue to happen in the future" and even get worse, Garner said.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
